200 related articles for article (PubMed ID: 23571732)
21. [Ezetimibe--pharmacokinetics and therapeutics].
Araújo RG; Casella Filho A; Chagas AC
Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():20-4. PubMed ID: 16400393
[TBL] [Abstract][Full Text] [Related]
22. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
Robinson JG; Davidson MH
Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):461-76. PubMed ID: 16918265
[TBL] [Abstract][Full Text] [Related]
23. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
[TBL] [Abstract][Full Text] [Related]
24. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
Geiss HC; Otto C; Parhofer KG
Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435
[TBL] [Abstract][Full Text] [Related]
25. Lipid-lowering effects of ezetimibe and simvastatin in combination.
Ijioma N; Robinson JG
Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):131-45. PubMed ID: 21453210
[TBL] [Abstract][Full Text] [Related]
26. Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe.
Kater AL; Batista MC; Ferreira SR
Metabolism; 2010 Jun; 59(6):921-6. PubMed ID: 20199786
[TBL] [Abstract][Full Text] [Related]
27. Drug-induced effects on cholesterol catabolism and bile acids.
Gylling H; Miettinen TA
Curr Opin Investig Drugs; 2006 Mar; 7(3):214-8. PubMed ID: 16555681
[TBL] [Abstract][Full Text] [Related]
28. Ezetimibe/simvastatin.
Montecucco F; Quercioli A; Mach F
Expert Opin Drug Saf; 2009 Nov; 8(6):715-25. PubMed ID: 19968571
[TBL] [Abstract][Full Text] [Related]
29. Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia.
Florentin M; Liberopoulos EN; Mikhailidis DP; Elisaf MS
Curr Med Res Opin; 2008 Apr; 24(4):995-1009. PubMed ID: 18291066
[TBL] [Abstract][Full Text] [Related]
30. Combinations of ezetimibe with nonstatin drug regimens affecting lipid metabolism.
Agouridis AP; Filippatos TD; Tsimihodimos V; Elisaf MS
Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):355-66. PubMed ID: 21438815
[TBL] [Abstract][Full Text] [Related]
31. Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.
Wang HH; Portincasa P; de Bari O; Liu KJ; Garruti G; Neuschwander-Tetri BA; Wang DQ
Eur J Clin Invest; 2013 Apr; 43(4):413-26. PubMed ID: 23419155
[TBL] [Abstract][Full Text] [Related]
32. [Dual inhibition of cholesterol using the drug combination ezetimibe/simvastatin?].
Vaverková H
Vnitr Lek; 2007 Apr; 53(4):421-7. PubMed ID: 17578178
[TBL] [Abstract][Full Text] [Related]
33. [Cholesterol absorption as a target for the treatment of hypercholesterolemia].
Bitzur R; Cohen H; Harats D
Harefuah; 2006 Nov; 145(11):831-5, 861, 860. PubMed ID: 17183957
[TBL] [Abstract][Full Text] [Related]
34. Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials.
Sweeney ME; Johnson RR
Expert Opin Drug Metab Toxicol; 2007 Jun; 3(3):441-50. PubMed ID: 17539750
[TBL] [Abstract][Full Text] [Related]
35. Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant.
Ahmed MH; Khalil AA
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1021-9. PubMed ID: 21060168
[TBL] [Abstract][Full Text] [Related]
36. Clinical use of ezetimibe.
Cheng AY; Leiter LA
Can J Clin Pharmacol; 2003; 10 Suppl A():21A-5A. PubMed ID: 14571302
[TBL] [Abstract][Full Text] [Related]
37. Effects of ezetimibe add-on to statin therapy on adipokine production in patients with metabolic syndrome and stable vascular disease.
Gupta M; Szmitko PE; Tsigoulis M; Braga MF; Kajil M; Herjikaka S; Quan A; Teoh H; Verma S
J Cardiovasc Pharmacol; 2010 Sep; 56(3):241-5. PubMed ID: 20505518
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of intestinal cholesterol absorption by ezetimibe is a novel therapeutic target for fatty liver.
Yamagishi S; Nakamura K; Matsui T; Sato T; Takeuchi M
Med Hypotheses; 2006; 66(4):844-6. PubMed ID: 16188393
[TBL] [Abstract][Full Text] [Related]
39. Is there a problem with ezetimibe or just ENHANCEd hype?
Whayne TF
Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
[No Abstract] [Full Text] [Related]
40. Ezetimibe: a novel option for lowering cholesterol.
Davidson MH
Expert Rev Cardiovasc Ther; 2003 May; 1(1):11-21. PubMed ID: 15030293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]